United Kingdom

He regularly writes for the sector’s leading publications including HealthInvestor and Caring Times, and is often sought out by the national press, including the Financial Times, for his opinions. He trained as a chartered accountant with KPMG before moving onto the corporate development team of the then FTSE 100 company, Boots plc.

Steve focuses on financial sponsors (private equity) activity and regularly advises business owners, management teams and private equity funds on management buy-outs and growth capital investments. He trained as a chartered accountant with Coopers & Lybrand (now PwC), moving into their corporate finance team before becoming an Investment Director at a mid-market private equity firm.

Andy’s corporate finance career spans over 25 years, working with a range of clients on both UK and international transactions. He has a particular focus on businesses such as consultancies and professional services firms. He is also experienced in advising on private equity, bank consortia and other complex shareholder structures.

He qualified as a chartered accountant with RSM Robson Rhodes and worked in their London lead advisory team for eight years. Richard is fluent in French and during his time at Robson Rhodes, he spent a year seconded to a corporate finance boutique in Paris.

As a lender, Andrew worked for a range of institutions including Kaupthing, where he was the head of the acquisition and leveraged finance team. In 2007 Andrew, joined Hawkpoint Partners, and then Stephens Europe, to lead their debt advisory practice. Andrew joined Alantra in 2017.
Over the past 10 years, Andrew has delivered leverage solutions for both private equity and corporate clients.

Keith primarily works with private company owners and management teams on company sales and private equity transactions. A Fellow of the Institute of Chartered Accountants of England and Wales, Keith spent his initial career at the successor firms of PwC and Deloitte, including a three-year period in the Far East, operating out of Hong Kong.

Across his career Richard has led over 100 transactions, with a significant focus on advising private company shareholders on trade sales and private equity investments.
Prior to joining Alantra’s predecessor firm, Richard qualified as a chartered accountant with Grant Thornton, subsequently moving to Ernst & Young’s corporate finance team, which included a secondment to a major bank’s restructuring team.

Prior to joining Alantra’s predecessor firm in 2013, Andrew worked at Barclays Capital where he was Global Head of Debt Advisory and one of the senior Managing Directors working in European Leveraged Finance. Andrew has extensive experience across a broad array of debt instruments, including high yield capital markets, loans, securitisation, asset backed, bonds, amendments & waivers.

Matthew joined Alantra in 2017, prior to which he co-founded a specialist beauty and wellbeing M&A advisory firm. Before this, he worked at PwC and Close Brothers Corporate Finance.
Matthew has advised many multi-national and private owners of household, personal care and beauty assets globally, including the sales of market-leading brands including Bulldog, REN Skincare, Batiste Dry Shampoo and Liz Earle.

Simon’s main focus is on the food and beverage industry, building on the eight years he spent delivering M&A and strategic financial planning projects at United Biscuits prior to joining Alantra’s predecessor firm in 2007. Simon is the author of The Grocer Fast 50, which identifies the 50 fastest-growing privately owned food and beverage companies published annually in the sector’s leading publication.

Anthony is a Partner at Alantra with over 15 years of M&A experience in the healthcare sector.

He is recognised as one of the leading advisors in the pharma services sector. Anthony has worked on more than 40 M&A transactions and a variety of strategic advisory projects for a range of clients in the UK, US, Europe and Asia.

Prior to joining Alantra, Anthony held positions in the healthcare teams at Bear Sterns and Rothschild. He has advised high-profile pharma services business including Cherry Healthcare on its sale to Avenir Global, Prescient Healthcare Group on the investment from Baird Capital, Lucid Group on the investment from LDC, STEM on its £84m sale to UDG plc and Hive on its £50m sale to St Ives plc. Anthony also sits on the awards judging panel for healthcare industry body Communiqué.

Away from work, Anthony is a keen rugby player.

James has more than 12 years of experience in TMT M&A, with particular focus within the voice and networking, unified communications, IT support and services, cloud and managed services and software sectors.

Prior to joining Alantra, James worked at Oakley Advisory where he completed more than 30 transactions in mid-market technology and telecoms for a range of clients across the UK, Europe and the US. Notable transactions have included advising Adarma (formerly ECS Security) on its MBO supported by Livingbridge; Southern Communications on its minority fundraise and subsequent refinancing; and CSI on its investment from MML Capital Partners.

Outside of work James enjoys spending as much time as possible with his wife and his two young boys (at least when the boys aren’t driving him completely insane).

Before joining Alantra’s predecessor firm in November 2013, Bobby spent three years with DC Advisory in both the M&A and Debt Advisory teams and prior to that, four years at Zeus Capital, which included public company advisory work.

Over the last 15 years, he has advised business owners and management teams on private equity, growth capital and trade sale transactions. He qualified as a chartered accountant with Deloitte in their Technology sector team, prior to joining Alantra’s predecessor firm in 2006.

Charles joined Alantra in 2017 from a Food & Beverage advisory boutique. He has significant experience of advising market-leading, high-growth brands such as Ella’s Kitchen, nakd/Trek and Butterkist and has strong contacts with both multinational and regional food groups.

Specifically, he works on buy and sell-side opportunities, with a strong emphasis on the Business Services and Waste & Clean Technology sectors. He is a co-author of the CIWM Waste Fast 50

After qualifying as a chartered accountant with PwC, Paul spent a number of years working at premium automotive franchises, most recently at the BMW franchisee, Bedfordia Automotive, where he helped to grow the business over a 10-year period before working with the owners on their exit.

Prior to joining Alantra’s predecessor firm in 2015, Guy was a Director in the mid-market leverage team at CIT, Bank where he focused primarily on transaction values between £50m and £250m, lending to both corporates and financial sponsors

Paul has completed a wide range of deal types in a number of sectors, with a particular focus in the Technology sector. He trained as a chartered accountant with Deloitte, moving after six years to Arbuthnot Securities, where he worked in corporate finance advising high-growth companies. Prior to joining Alantra’s predecessor firm in 2011, Paul worked as a consultant to the Government on the Automotive Assistance Fund.

Tom focuses on the Healthcare Technology and Pharmaceuticals sectors. In respect of the latter, he is one of the authors of the Alantra Pharma Fast 50.

Tom qualified as a chartered accountant with PwC, and after gaining due diligence experience, Tom joined Alantra’s predecessor firm in 2013.